266 related articles for article (PubMed ID: 12175725)
1. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
Zhu F; Eckels DD
Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
Kurokohchi K; Akatsuka T; Pendleton CD; Takamizawa A; Nishioka M; Battegay M; Feinstone SM; Berzofsky JA
J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531
[TBL] [Abstract][Full Text] [Related]
4. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
Sarobe P; Huarte E; Lasarte JJ; López-Díaz de Cerio A; García N; Borrás-Cuesta F; Prieto J
J Hepatol; 2001 Feb; 34(2):321-9. PubMed ID: 11281563
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response.
Wang JH; Layden TJ; Eckels DD
Hum Immunol; 2003 Jul; 64(7):662-73. PubMed ID: 12826368
[TBL] [Abstract][Full Text] [Related]
7. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
[TBL] [Abstract][Full Text] [Related]
8. Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus.
Kuprianov VV; Nikolaeva LI; Zykova AA; Dedova AV; Grishechkin AE; Kapustin IV; Kotlyarov RY; Ravin NV
Virus Res; 2020 Jul; 284():197984. PubMed ID: 32325116
[TBL] [Abstract][Full Text] [Related]
9. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
10. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
[TBL] [Abstract][Full Text] [Related]
11. Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein.
Martin P; Parroche P; Pajot A; Chatel L; Barreto C; Touat L; Dubois V; Rohrlich PS; Bain C; Trépo C; Negro F; Inchauspé G; Fournillier A
Microbes Infect; 2006 Aug; 8(9-10):2432-41. PubMed ID: 16859951
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
[TBL] [Abstract][Full Text] [Related]
13. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
[TBL] [Abstract][Full Text] [Related]
14. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
Battegay M; Fikes J; Di Bisceglie AM; Wentworth PA; Sette A; Celis E; Ching WM; Grakoui A; Rice CM; Kurokohchi K
J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
[TBL] [Abstract][Full Text] [Related]
15. Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity.
Wang S; Buchli R; Schiller J; Gao J; VanGundy RS; Hildebrand WH; Eckels DD
World J Gastroenterol; 2010 Apr; 16(16):1953-69. PubMed ID: 20419832
[TBL] [Abstract][Full Text] [Related]
16. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.
Oseroff C; Sette A; Wentworth P; Celis E; Maewal A; Dahlberg C; Fikes J; Kubo RT; Chesnut RW; Grey HM; Alexander J
Vaccine; 1998 May; 16(8):823-33. PubMed ID: 9627940
[TBL] [Abstract][Full Text] [Related]
17. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
Hiranuma K; Tamaki S; Nishimura Y; Kusuki S; Isogawa M; Kim G; Kaito M; Kuribayashi K; Adachi Y; Yasutomi Y
J Gen Virol; 1999 Jan; 80 ( Pt 1)():187-193. PubMed ID: 9934701
[TBL] [Abstract][Full Text] [Related]
18. [Long-term evolution of C-terminal of HCV NS3 protein containing the predicted CTL epitopes in two HCV patients].
Wang T; Guo H; Wang G
Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):207-10. PubMed ID: 10715788
[TBL] [Abstract][Full Text] [Related]
19. Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis.
Sreenarasimhaiah J; Jaramillo A; Crippin J; Lisker-Melman M; Chapman WC; Mohanakumar T
Hum Immunol; 2003 Feb; 64(2):224-30. PubMed ID: 12559624
[TBL] [Abstract][Full Text] [Related]
20. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
Shirai M; Chen M; Arichi T; Masaki T; Nishioka M; Newman M; Nakazawa T; Feinstone SM; Berzofsky JA
J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
